Oct 08, 2024
New research from The Wistar Institute's Salvino lab, led by professor Joseph Salvino, Ph.D., has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that—according to preclinical testing—effectively inhibit COVID-19 and synergize with existing anti-COVID therapies.
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service